# PH94B in the Treatment of Adjustment Disorder With Anxiety

> **NCT04404192** · PHASE2 · COMPLETED · sponsor: **VistaGen Therapeutics, Inc.** · enrollment: 41 (actual)

## Conditions studied

- Adjustment Disorder With Anxious Mood

## Interventions

- **DRUG:** PH94B
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04404192
- **Lead sponsor:** VistaGen Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-12
- **Primary completion:** 2022-12-14
- **Final completion:** 2022-12-14
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2026-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04404192

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04404192, "PH94B in the Treatment of Adjustment Disorder With Anxiety". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04404192. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*